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Summary
This chapter provides an overview of psychological 
treatment options for irritable bowel syndrome. After 
briefly introducing each treatment modality, the focus lies 
on recent evidence supporting their efficacy. Cognitive-
behavioral psychotherapy is the best-studied treatment 
option, followed by hypnotherapy and other promising 
treatments including patient (psycho) education and 
various forms of biofeedback. Further research is needed 
to overcome the limitations of current studies as well as to 
identify the ‘active components’ responsible for the efficacy 
of psychological treatments of IBS.
Learning points
After reading this chapter you will know:
•	 Irritable bowel syndrome is a ‘functional somatic syndrome’ re-
sulting from an interaction between biological, psychological and 
social factors.
•	 Psychological factors may interfere with brain processing of viscer-
al signals as well as with gut physiology (through the autonomic 
nervous system) in the generation of IBS symptoms, providing a 
rationale for psychological treatment.
•	 Psychotherapy, especially cognitive-behavioral therapy is the best 
studied psychological treatment modality showing benefit in IBS, 
followed by hypnotherapy.
•	 Patient education and various forms of biofeedback are other 
promising treatment options.
•	 Further research is needed to identify the active components of 
these different treatment modalities as well as to overcome meth-
odological limitations, which is needed to tailor these treatment 
options better to individual patients’ needs.
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Increasing evidence suggests that there 
are overlapping mechanisms underlying 
‘functional somatic syndromes’ 
(Box 7.1) [1], including an autonomic 
imbalance and abnormal interoceptive 
processes in the CNS. The latter means 
that the brain processes and modulates 
bodily signals in an abnormal way, 
causing these signals to be perceived as 
(painful) physical symptoms. Importantly, 
both these pathophysiological processes 
may be influenced by psychological 
factors and/or psychiatric comorbidity. 
In irritable bowel syndrome (IBS), 
Naliboff et al. [2] suggest that altered 
autonomic balance causes altered bowel 
habits, stress-induced hyperalgesia 
results in abdominal pain/discomfort 
and enhanced activation of ascending 
arousal systems creates hypervigilance 
towards sensory stimuli. In addition 
to the physiological dysregulation, 
conditioned fear responses, avoidance 
behavior and ‘unhelpful’ cognitions can 
be important maintaining factors in the 
chronicity of IBS symptoms.
Based on these observations, several 
nonpharmacological interventions 
involving changes in behavior and/or 
Box 7.1. Heart rate variability.
•	 Heart rate variability (HRV) is a measure of interbeat interval fluctuations in heart 
rate and is emerging as a possible descriptor of the brain functional organization 
contributing to homeostasis. 
•	 HRV has been considered to be an inferential index of prefrontal inhibitory 
capacity and is shown to be linked to cognitive performance [37,38]. Commonly 
used indices are frequency domain and time domain measures. Three 
components can be identified in the frequency domain: a very low frequency 
component (VLF) that corresponds to the power below 0.04(or 0.05) Hz, a 
low-frequency (LF) component centered around 0.1 Hz, and a high frequency 
(HF) component that corresponds to the (normal) respiratory frequency band 
(0.15–0.4 Hz).
•	 Efferent vagal (parasympathetic) activity is a major contributor to the HF 
component. In addition, respiratory sinus arrhythmia (RSA) is referred to as the 
naturally occurring variation in heart rate that occurs during a breathing cycle and 
is also a measure of parasympathetic nervous system activity. Lower resting HRV 
values are found in patients with functional syndromes [39].
•	 The midbrain periaqueductal gray area mediates pain modulation through the 
autonomic nervous system. The ventral portion increases parasympathetic activity 
and reduces the response to pain.
•	 Pereira and colleagues showed that HF power significantly increased and the 
LF/HF power ratio decreased following stimulation of the ventral portion in 
patients with chronic or unexplained pain [40]. In addition, the severity of 
abdominal pain was negatively related to HF power and positively related to the 
LF/HF ratio in constipation-predominant IBS patients [41].
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cognition have been studied for patients 
with IBS. It has been proposed that 
these interventions may impact on 
stress-related brain–gut interactions 
and interfere with cortical brain circuits 
involved in pain modulation [3]. 
Examples of these interventions include 
patient education, hypnotherapy, 
cognitive behavioral therapy (CBT), 
relaxation and biofeedback training. 
As relaxation training is often included 
as a component of other interventions 
(such as CBT or biofeedback) and has 
also been used as a control condition 
for other psychological treatments, it 
will not be described separately.
Patient education
Patients with IBS have to cope not only 
with their symptoms but also with 
the social stigma that is still attached 
to functional somatic syndromes. 
The diffuse symptomatology, unclear 
etiology and lack of medical diagnosis 
and clear-cut treatment strategy may 
frustrate doctors when dealing with 
these patients, who are frequently 
considered to be ‘difficult’ and ‘time-
consuming’. IBS patients have often 
felt misunderstood because physicians 
have not taken their problems seriously. 
Therefore, a strong demand exists 
for more information and instruction 
about their disorder [4].
Bengtsson and colleagues found 
that educating women with IBS 
on medical care, physical activity, 
stress management (SM), diet and 
health insurance led to significant 
improvements in vitality and abdominal 
pain as well as to a reduced number 
of healthcare visits [5]. These results 
Functional somatic syndromes: irritable bowel syndrome (IBS) can 
be conceptualized as one of many so-called ‘functional somatic 
syndromes’ (FSS), including fibromyalgia, chronic fatigue syndrome, 
multiple chemical sensitivity, non-cardiac chest pain, (Gulf) war 
syndrome, chronic hyperventilation syndrome, and many others. To 
date, there are no confirmed biomarkers that are distinctive of different FSS. On 
the other hand, there is substantial overlap in case definitions for different FSS 
and the patients identified by those diagnoses overlap considerably. Another 
reason for arguing that FSS are closely related is the fact that they share many 
non-symptom characteristics, such as female predominance, substantial correla-
tions with negative affectivity, psychiatric comorbidity (e.g., anxiety and depres-
sion), impairments in functional status or quality of life, excessive healthcare use, 
response to the same nonpharmacological therapies, and others [1].
Irritable bowel syndrome: a very common functional digestive disorder char-
acterized by abdominal pain or discomfort (including bloating) and disturbed 
defecation with no clear biochemical or structural abnormalities.
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call for an implementation of patient 
education as part of a multicomponent 
treatment program. Other research 
has confirmed the effectiveness of 
psychoeducation group treatments 
relative to usual care in IBS [6,7].
Gut-directed hypnotherapy
In a landmark study published in 
the Lancet in 1984, Whorwell and 
colleagues first demonstrated the 
superior efficacy of hypnotherapy 
compared with psychotherapy and 
placebo on core IBS symptoms 
(abdominal pain, bowel habit) and 
general wellbeing in 30 refractory 
patients [8]. Another Lancet publi-
cation in 1989 demonstrated that 
group hypnotherapy is as effective as 
individual treatment [9]. Since then, 
numerous other studies have been 
published and the topic has been 
the subject of several systematic 
reviews and meta-analyses, including 
a Cochrane review [10], with the most 
recent one being published in 2009 [11]. 
Although all these reviews emphasize 
important methodological limitations 
of most of the published studies 
(small sample size, lack of adequate 
control groups and interventions, 
lack of standardization of outcomes), 
the uniform conclusion is that the 
Cognitive behavioral therapy (CBT): based on the learning 
principles of classical and operant conditioning as well as on insights 
in cognitive research. CBT is most closely allied with the scientist–
practitioner model in which clinical practice and research support 
each other, with an emphasis on a clear operationalization of the 
problem, measuring changes in cognition and behavior and the attainment of 
goals. CBT is based on the idea that the autonomic arousal caused by ‘unhelpful’ 
thoughts and avoidance behavior may trigger the gastrointestinal symptoms, 
causing vicious circles. CBT interventions include education about IBS symptoms 
and their relationship to stress, self-monitoring of IBS symptoms, relaxation skills, 
restructuring of cognitions, attentional control skills, and (interoceptive) exposure. 
CBT is usually applied in the form of weekly 1-h sessions over a period of 
8–12 weeks.
Biofeedback: a method in which physiological signals are measured and viewed 
‘online’ by the therapist and patient by use of an instantaneous electronic display. 
The effect of a catastrophizing thought, attention, posture, way of breathing, and 
so on is thereby immediately visible. The goal is that the patient learns to recog-
nize his own bodily signals (awareness) and to influence them by use of oper-
ant conditioning principles (reinforcement of desired effects), first by use of the 
biofeedback equipment, and later without (process of internalization). Ultimately, 
the patient should be able to integrate and generalize the biofeedback modulated 
skills into his daily life.
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therapeutic effect of hypnotherapy 
on primary IBS symptoms is superior 
to waiting list control and usual 
medical management and that the 
effect appears to be long-lasting. 
A recent large Swedish randomized 
controlled trial demonstrated higher 
effectiveness of gut-directed hypno-
therapy (GDH) compared with supp-
ortive psychotherapy and waiting 
list control on core IBS symptoms in 
refractory patients, an effect that 
was sustained up to 1 year [12]. 
Therapeutic gains have been reported 
to be maintained up to 5 years after 
treatment [13,14]. Whorwell and 
colleagues demonstrated that positive 
mood, high alexithymia and presence 
of comorbid anxiety were predictors of 
a good response to hypnotherapy [15]. 
A recent high-quality large Austrian 
trial demonstrated efficacy of group 
GDH compared with supportive talks 
with medical treatment on IBS-related 
quality of life as well as psychological 
symptoms [16]. Furthermore, 
three randomized controlled trials 
demonstrating efficacy of GDH for 
IBS or functional abdominal pain have 
been published, as systematically 
reviewed in [17].
Despite this growing body of 
evidence for the efficacy of GDH as 
a treatment for IBS, the mechanisms 
of action of hypnotherapy remain 
elusive. A recent study did not find 
any effect on gastrointestinal motility 
parameters, including gastric emptying 
and small bowel and colonic transit 
time [14]. Vlieger et al. demonstrated 
that hypnotherapy does not have a 
significant effect on rectal sensitivity in 
children [18], whereas a normalization 
of rectal sensitivity after GDH has been 
shown in some, but not all, studies in 
Systematic review: an unbiased synthesis of the available research 
about a specific topic. Systematic reviews use a methodology for a 
comprehensive search of the literature for relevant studies based on 
a priori search terms or criteria. Thus, a bias-free list of citations is 
developed and those that do not fulfill the established criteria are 
not included. 
Gut-directed hypnotherapy (GDH): was first developed in Manchester (UK) in 
the early 1980s and teaches the patients the necessary hypnotic skills to control 
and help normalize gut function and symptoms. After an initial intake session de-
voted to history, reassurance about hypnosis and psychoeducation on gut func-
tion and gut–brain interactions, the patient attends up to 12 sessions of hypnotic 
induction and suggestions over a 3-month period. Hypnotic induction is achieved 
by the usual means, such as progressive relaxation and the suggestion of going 
to a special place. Gradually, more specific suggestions aimed at controlling and 
normalizing gut function are introduced.
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adults [11]. A study in adult patients 
showed that hypnotherapy reduces 
the sensory and motor component of 
the gastrocolonic response, which is 
exaggerated in IBS patients [19]. The 
vast majority of studies have shown 
an effect on stress, anxiety, depression 
and somatization, and some of these 
studies demonstrated an association 
between psychological improvement 
and improvement of core IBS symptoms 
[11]. Finally, there is rather limited 
evidence that GDH may influence 
autonomic nervous system activity [11].
In summary, there is growing evidence 
for the efficacy of GDH in IBS, although 
more high-quality trials, as have been 
published recently, are needed.
Cognitive behavioral 
therapy
CBT has been studied the most 
extensively of all psychological 
interventions and has been reported 
to be effective in the long term in 
individual and group treatment of IBS 
when compared with no treatment, 
standard medical care, placebo or 
active psychological interventions such 
as psychoeducation, supportive therapy 
or SM/stress reduction treatment 
[20–22]. A review and meta-analysis by 
Ford et al. showed that – from a range 
of different psychological therapies 
that were able to significantly reduce 
physical symptoms in patients with IBS 
– studies on CBT provided the strongest 
evidence, although it needs to be 
mentioned that this study only included 
two hypnotherapy studies that were 
not of the highest quality [20].
In a recent study, symptoms and 
disability caused by IBS were 
significantly more reduced at post-test 
level when using a combination of CBT 
and medical treatment compared with 
medical treatment alone [23]. Drossman 
and colleagues reported significantly 
greater improvements after 12 weeks 
CBT compared with education alone 
in women with moderate-to-severe 
functional bowel disorders [24]. 
However, in a rigorously conducted 
randomized-controlled trial the 
hypothesis that CBT would be superior 
to relaxation and standard care alone 
in IBS patients could not be confirmed 
[25], as patients in all three treatment 
groups improved significantly in terms 
of self-reported bowel symptoms. At 
the start of this study, patients within 
each experimental condition were 
provided with a detailed explanation of 
a biopsychosocial model of IBS as well 
as basic education about gut function 
coupled with dietary advice. A possible 
explanation for the results of this study 
could be that patient education might 
have been a critical component in the 
positive effects, for example by reducing 
uncertainty and fear for severe disease, 
as well as increasing self-efficacy.
Craske and colleagues ascribed 
110 IBS patients to one of three 
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experimental conditions, receiving 
ten sessions each: SM; an attention 
control, consisting of self-monitoring 
of IBS symptoms, reading educational 
material and discussing it with the 
therapist (attention by therapist [AT]); 
and CBT with interoceptive exposure 
(IE) to visceral sensations [26]. The 
IE treatment was based on a fear of 
visceral sensations conceptualization 
of IBS symptoms. IE narrows the 
focus of treatment to interoceptive 
(visceral) cues associated with the 
target symptoms, unlike SM, which 
attempts to alter coping responses 
to a broad range of exteroceptive 
(psychosocial) life stressors. They 
found no differences in outcome 
between SM and AT, while IE 
significantly outperformed AT on 
several outcome indices, including a 
measure of symptom severity as well 
as anxiety about symptoms and overall 
body vigilance, and outperformed SM 
in some domains, including symptom 
severity. The results highlight the 
importance of directly targeting fear 
and avoidance of visceral sensations 
using repeated interoceptive exposure.
Recently, studies have been 
conducted investigating CBT for IBS 
where patients had online therapist 
contact via the internet (ICBT). This is 
a promising cost-effective treatment 
modality as it can be offered to IBS 
patients on a much larger scale 
than conventional psychological 
treatments [27].
Another promising intervention mode 
– at least from a theoretical point of 
view – is acceptance and commitment 
therapy (ACT). ACT is a so-called 
‘third generation’ behavioral therapy 
based on the relational frame theory 
[28]. Some forms of CBT focus mainly 
on behavioral avoidance, sometimes 
neglecting experiential avoidance (i.e., 
avoiding all inner experiences such as 
aversive thoughts, feelings and somatic 
discomfort). Many individuals with IBS 
engage in a variety of experiential 
avoidance strategies, such as 
distraction or suppression of thoughts, 
feelings and bodily sensations. We 
believe that ACT may show merit 
as a treatment modality for IBS as a 
prime focus is given to experiential 
avoidance through interoceptive 
exposure. Specifically, ACT 
encourages interoceptive exposure 
while monitoring (i.e., observation 
and labeling) one’s thoughts, feelings 
and bodily sensations in a neutral, 
detached manner. Unlike cognitive 
therapy, which seeks to challenge 
the irrationality of thoughts, in 
ACT the content of the thought is 
not so relevant as its functionality 
(is it helpful for you or not?). The 
main goal of ACT is to increase 
psychological and physiological 
flexibility, by incorporating techniques 
of mindfulness (living in the present 
moment and engaging fully in what 
one is doing rather than ‘getting 
lost’ in ones thoughts), acceptance 
(allowing ones feelings, thoughts, 
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and sensations to be as they are, 
letting them come and go rather than 
trying to control them), metaphors, 
experiential exercises, value-guided 
behavioral interventions, and cognitive 
defusion. As such, IBS patients can 
learn how to stop ‘fighting’ their 
symptoms, but rather to perceive them 
as harmless – even if uncomfortable – 
transient inner events. Although ACT 
has been proven to be effective as a 
treatment for several disorders, direct 
studies of the efficacy of ACT for IBS 
do not yet exist.
Biofeedback
Colonic motility
The first attempts to treat IBS with 
biofeedback focused on modifying 
colonic motility. Furman tried to 
teach five patients with diarrhea-
predominant IBS to alternatively 
increase and decrease bowel sounds by 
use of an electronic stethoscope [29]. 
All patients reported improvement 
in symptoms, which was said to 
be correlated with learning control 
over bowel sounds. However, other 
researchers could not replicate these 
results [30]. Therefore, the efficacy of 
colon-motility oriented biofeedback as 
a treatment for IBS is questionable.
Biofeedback relaxation training
Relaxation training implemented 
through biofeedback has also been 
studied in patients with IBS. Blanchard 
and colleagues repeatedly found a 
multicomponent biofeedback train-
ing protocol (progressive muscle 
relaxation, thermal biofeedback, cog-
nitive therapy and education) to be 
more effective than a waiting list 
condition [31,32]. However, when 
multicomponent treatment was 
compared with an attention-placebo 
condition (pseudomeditation and 
electroencephalogram a-suppression 
biofeedback), it was no more effective 
than placebo [33], suggesting that 
wait-list control groups do not 
adequately control for expectancy 
(placebo).
Autonomic nervous system
Several researchers have established 
that dysregulation of the autonomic 
nervous system is a component of 
IBS [34,35]. Given this autonomic 
imbalance in IBS patients, biofeedback 
training has also been used to decrease 
body muscle tension and sympathetic 
activity. Leahy et al. developed a 
computerized biofeedback game 
that relates variations in stress level 
to animated computer graphics, by 
monitoring electrodermal activity 
[36]. Symptom scores in 40 IBS 
patients were improved using this 
device, for approximately half of them 
over a period of 3 months. However, 
the fact that there was no control 
group nor long-term follow-up was 
an important limitation.
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Heart rate variability (HRV) bio-
feedback is designed specifically to 
target autonomic reactivity, primarily 
influencing the parasympathetic 
system and producing major increases 
in gain in the heart rate baroreflex 
closed loop (Box 7.1) [37–41]. When 
respiratory sinus arrhythmia is put in 
phase with respiration, baroreflexes 
are triggered and efficacy of 
respiratory gas exchange is increased.
Also, HRV biofeedback benefits from 
being noninvasive and having a high 
benefit–cost ratio. Preliminary results 
have shown that HRV biofeedback 
may have important effects on 
autonomic symptoms and on quality 
of life and pain in fibromyalgia 
[42]. Humphreys and Gevirtz also 
showed that in a sample of children 
with functional abdominal pain, the 
symptoms were improved after HRV 
biofeedback and a change in vagal 
tone was suggested as the potential 
mediator for this improvement [43]. In 
general, HRV biofeedback is a rather 
new, yet promising treatment tool.
Electromyography
Clinical applications of electro-
myographic (EMG)-based bio feedback 
therapy supported by randomized, 
controlled trials (RCTs) are limited. 
Patients can be taught to improve 
their capacity to voluntarily contract 
the external anal sphincter during 
rectal filling, either by improving the 
strength of the anal sphincter and 
improving squeeze duration (motor 
skills training), increasing the ability to 
perceive mild rectal sensations (sensory 
discrimination training), or combining 
both mechanisms (coordination 
training). For fecal incontinence, RCTs 
suggest that biofeedback combining 
strength training and sensory 
discrimination training is effective 
in approximately 75% of patients 
and is more effective than placebo. 
For dyssynergic defe cation, RCTs 
show that biofeedback combining 
pelvic floor muscle relaxation 
training, practice in defecating a 
water-filled balloon, and instruction 
in effective straining is efficient in 
approximately 70% of patients who 
have failed to respond to laxative 
treatment. For both incontinence 
and dyssynergic defecation, the 
benefits of biofeedback last at least 
12 months. A meta-analytic review of 
biofeedback treatment of constipation 
examined seven RCTs, comparing 
biofeedback with non-biofeedback 
modalities (e.g., laxatives, conservative 
management; n = 3) or comparing 
various biofeedback treatments, 
such as EMG versus balloon 
biofeedback (n = 4; [44]). Biofeedback 
produced a sixfold improvement in 
constipation symptoms compared 
with nonbiofeedback treatments. 
Furthermore, EMG biofeedback pro-
duced an almost sevenfold improve-
ment compared with non-EMG 
biofeedback.
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There are, however, important limit-
ations to all aforementioned EMG 
studies. Only a few RCTs used an 
adequate control group, such as sham 
biofeedback. Several studies suffered 
from problems in standardization 
of outcome measures and double-
blinding. In future research more 
solid research protocols using a 
well-designed control treatment are 
required to test whether biofeedback 
has a unique effect over and above 
nonspecific factors such as support, 
attention, expectancy to benefit from 
the training, the use of cognitive 
and emotion-regulation techniques 
and relaxation. In addition, simply 
the use of technologically impressive 
equipment and the presentation of a 
clear and plausible explanation for the 
complaints might improve self-efficacy 
and cause the larger effect.
One exception is the recent study of 
Hart et al., in which the efficacy of 
anorectal biofeedback (AB; learning to 
isolate the anal sphincter using an EMG 
probe) for constipation was compared 
with a biofeedback control (learning to 
relax trapezius or temporalis muscles 
with EMG feedback) treatment [45]. 
They further investigated the extent to 
which self-reported childhood sexual/
physical abuse predicted biofeedback 
outcome. Biofeedback therapy target-
ing the trapezius muscle has been 
found to alleviate temporomandibular 
joint pain, tension headache, chronic 
orofacial pain and chronic back pain, 
but does not appear to benefit pelvic 
floor relaxation and bowel function 
and has an effect only on the targeted 
muscle group [46]. Consequently, it is 
a suitable control for the ‘nonspecific’ 
effects of AB (e.g., establishment of 
a therapeutic relationship, instruction 
in relaxation of a muscle group and 
attending sessions at a medical center). 
Study results showed that only AB 
produced clinical improvements in 
constipation severity and quality of life. 
The data also suggest that a history of 
childhood sexual and physical abuse 
may be associated with diminished 
improvement after biofeedback for 
pain severity and impaired mental 
quality of life. Unfortunately, a 
longer term follow-up period is 
lacking in this study. A recent study 
of Patcharatrakul and Gonlachanvit 
showed that the presence of IBS in 
dyssynergic defecation did not affect 
the outcome of biofeedback therapy 
[47]. In addition, treating dyssynergic 
defecation patients with IBS by 
biofeedback therapy improved both 
constipation and other IBS symptoms.
The future of biofeedback 
therapy
Overall, the future of biofeedback 
therapy depends on improving research 
methodology. RCTs on dyssynergic 
defecation and fecal incontinence 
have shown that studies with 
adequate study samples, standardized 
treatment protocols and outcomes, 
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and adequate length of follow-up 
yield more consistent results. There are 
many reasons why biofeedback may be 
an interesting therapeutic tool in IBS. 
First of all, it helps making the invisible 
visible. Physiological monitoring can 
help to uncover abnormal physiological 
patterns (i.e., autonomic imbalance) 
and to evaluate changes that occur 
as a result of treatment interventions. 
Secondly, biofeedback therapy might 
be more appealing to patients with IBS 
than traditional psychotherapy. These 
patients often have the feeling that 
their physicians see their symptoms as 
‘all in the mind’. Such questioning of 
the legitimacy of the symptoms puts 
the patients in the position of having 
to prove that they are ill. This often 
leads to dualistic thinking on behalf 
of the patient, wanting to prove that 
the problem is all in the body, not the 
mind. Biofeedback specifically targets 
physiological processes that are 
thought to be related to the patient’s 
complaint. In this way, biofeedback 
can become a ‘Trojan horse’ technique 
for helping such patients become 
aware of and deal with the emotional 
issues that may produce the physical 
complaints. It could therefore generate 
increased treatment acceptance and 
adherence as well as a larger sense of 
self-efficacy [48].
Conclusion
To date CBT remains the most effective 
psychological treatment for IBS, based 
on the outcome and number of sound 
RCTs compared with other modalities.
Although the majority of the studies 
mentioned in this chapter have 
reported a positive effect of the 
psychological interventions studied, 
a lot of them suffer from substantial 
methodological limitations. Further 
research should deal with issues such 
as adequate blinding of conditions, 
use of validated outcome measures, 
larger sample sizes, a definition 
of IBS according to standardized 
criteria and long-term follow-ups. 
Moreover, to date, it is not yet clear 
whether psychological treatments 
are more effective than psychotropic 
agents in the management of IBS, 
although some study results show the 
superiority of psychological treatments 
over antidepressants in terms of long-
term reduction in healthcare costs [49]. 
Studies comparing both treatment 
modalities of IBS are needed urgently.
Furthermore, an analysis of the critical 
underlying mechanisms causing 
beneficial changes in attentional, 
cognitive and emotional factors, 
as well as in interoceptive accuracy 
of gastrointestinal sensations is 
needed. Also, disentangling the 
effects of different components 
in multicomponent approaches 
would be interesting. For example, 
biofeedback is based on the same 
learning principles as CBT. Therefore, 
combining both might be a promising 
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treatment strategy for IBS, begging 
further research. Future research 
should also focus on the refinement 
of treatment packages in function 
of patient characteristics, symptom 
severity and illness duration.
Adding education about the 
biopsychosocial model of IBS to 
standard medical care can enhance 
treatment effects. In our opinion, 
further psychological treatment for IBS 
should be recommended for patients: 
for whom standard medical care 
does not sufficiently work after a few 
months; for those reporting several 
other physical symptoms besides the 
typical IBS related ones (e.g., high 
symptom reporters); for patients with 
problematic coping skills; and for 
patients with a history of physical, sexual 
or emotional abuse/neglect and/or 
psychiatric co-morbidity. A combination 
of medical management, CBT, 
hypnosis and biofeedback might be an 
interesting approach, paying attention 
to specific patient characteristics such 
as hypnotizability, personality, trauma, 
presence of maintaining factors 
such as catastrophizing, avoidance, 
hypervigilance towards symptoms, and 
so on. A good referral therefore requires 
sound diagnostical work (e.g., medical 
tests, psychophysiological measures, 
questionnaires and interview) as 
well as adequate doctor–patient 
communication.
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Multiple choice questions
1. Which psychological treatment option for irritable bowel syndrome 





2. Which physiological parameter has not been studied as a potential 
target for biofeedback therapy?
a. Autonomic nervous system function, for example, heart 
rate variability
b. Electromyography
c. Stress hormone system function
d. Colonic motility
3. Which key component of cognitive-behavioral psychotherapy 
might be crucial in the treatment of IBS?
a. Behavioral activation
b. Interoceptive exposure
c. Challenging the irrationality of thoughts
d. Stress management
4. What is not typical for a functional somatic syndrome?
a. Male predominance
b. The presence of an autonomic imbalance and abnormal 
interoceptive processes in the CNS
c. Difficult doctor–patient relationship
d. Positive response to psychological treatment
